Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
404 participants
OBSERVATIONAL
2025-02-11
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transition From Paediatric Intensive Care to General Paediatrics and Pneumology Units : a Study of the Post-intensive Care Syndrome
NCT05587595
Family Care Conferences Criteria in the Pediatric Intensive Care Unit
NCT04298281
Mortality in Pediatric Intensive Care Unit
NCT02961153
Outcome of Patients Admitted to Pediatric Intensive Care for Acute Respiratory Failure
NCT06470932
Singapore's Health Outcomes After Critical Illness in Kids
NCT04637113
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. \[Primary\] To characterize physical and cognitive health outcomes of PICU survivors.
2. \[Primary\] To investigate subgroups of critically ill children who have poor medium-term physical and cognitive health outcomes.
3. \[Primary\] To elucidate risk factors for poor physical and cognitive health outcomes in PICU survivors.
4. \[Exploratory\] To investigate the impact of physical and cognitive health of PICU survivors on overall family health.
The objectives of Singapore Health outcomes After Critical illness in Kids - Siblings (SHACK-S): Health Outcomes and Experiences of Healthy Siblings in the first 6 months after PICU discharge are:
1. \[Primary\] To describe and compare quality-of-life in healthy siblings at 1, 3 and 6 months after PICU discharge.
2. \[Primary\] To explore the experiences and support needs of healthy siblings 6 months after PICU discharge of a critically ill child.
3. \[Secondary\] To examine the experiences of recovery trajectory of healthy siblings.
Thus, HOPE cohort will provide information and insight regarding which groups of PICU patients and associated PICU therapies are associated with the highest risk for poor survivorship. The conduct of this study will also allow us to identify the challenges and find appropriate solutions in performing a cohort study with an emphasis on patient-reported outcomes (e.g., functional status, cognition and quality of life). Concurrently, the SHACK-S cohort will provide insights to understand the impacts of PICU admission on siblings and their recovery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HOPE Cohort (PICU Survivors)
Helping to Optimize Patients' Experiences (HOPE) after Pediatric Critical Illness Cohort Study \[Sample Size: 240 participants\]
This is a non-interventional study.
This is a non-interventional study.
SHACK-S Cohort (Siblings of PICU Survivors)
Singapore Health outcomes After Critical illness in Kids - Siblings (SHACK-S): Experiences and Health Outcomes of Siblings in the first 6 months after PICU discharge of a critically ill child. \[Sample Size (Quantitative): 164 participants; Sample Size (Qualitative): 20 participants\]
This is a non-interventional study.
This is a non-interventional study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
This is a non-interventional study.
This is a non-interventional study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Between 28 days - 16 years of age at PICU admission
2. Have an expected PICU stay \> 48 hours
\[SHACK-S Cohort\]
1. Healthy children (aged 4 -16 years old) with critically ill sibling between 28 days - 16 years of age at PICU admission
2. Has a critically ill sibling who has an expected PICU stay \> 48 hours
3. Lives in the same household as the critically ill sibling and parents prior to admission
Exclusion Criteria
1. Do-Not-Resuscitate status
2. Lack of informed consent
3. Prior enrolment in this study
\[SHACK-S Cohort\]
1. Children of critically ill sibling with Do-Not-Resuscitate status
2. Children with condition listed on paediatric Complex Chronic Conditions (CCC) system Version 3.0 or with neurocognitive/neurodevelopmental delays or disorders
3. Previous admission to PICU
4. Lack of informed consent
5. Prior enrolment in this study
28 Days
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National University Hospital, Singapore
OTHER
Duke-NUS Graduate Medical School
OTHER
KK Women's and Children's Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jan Hau Lee
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
A/Prof Lee Jan Hau, MBBS, MRCPCH, MCI
Role: PRINCIPAL_INVESTIGATOR
KK Women's and Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National University Singapore
Singapore, Singapore, Singapore
KK Women's and Children's Hospital
Singapore, Singapore, Singapore
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ECOS Ref: 2024-3978
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.